NEW YORK (GenomeWeb News) — Galapagos’ BioFocus DPI division today said it has received an extension of its certification from the International Standards Organization for its target discovery operations in its Leiden, the Netherlands.
 
BioFocus, which specializes in adenoviral agents and compound libraries for drug development, said the certification covers the chemical and biological research services it offers to pharma, biotech and agrochem businesses.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.